Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins.
about
New perspectives in glioblastoma antiangiogenic therapyOncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.Japanese apricot extract (MK615) potentiates bendamustine-induced apoptosis via impairment of the DNA damage response in lymphoma cells.Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.
P2860
Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@en
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@nl
type
label
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@en
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@nl
prefLabel
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@en
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@nl
P2093
P2860
P356
P1476
Everolimus enhances the cytoto ...... ogression regulatory proteins.
@en
P2093
P2860
P304
P356
10.1093/ABBS/GMT054
P577
2013-05-20T00:00:00Z